{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:31:36Z","timestamp":1788240696907,"version":"build-2803163510"},"reference-count":90,"publisher":"Elsevier BV","issue":"5","content-domain":{"domain":["ijaaonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.ijantimicag.2013.12.009","type":"journal-article","created":{"date-parts":[[2014,1,22]],"date-time":"2014-01-22T17:47:14Z","timestamp":1390412834000},"page":"395-402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":134,"title":["Combination of fluconazole with non-antifungal agents: A promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery"],"prefix":"10.1016","volume":"43","author":[{"given":"Shuyuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinglong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0005","first-page":"175","article-title":"Epidemiology and treatment approaches in management of invasive fungal infections","volume":"3","author":"Kriengkauykiat","year":"2011","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1471-2334-13-82","article-title":"Frequent detection of \u2018azole\u2019 resistant Candida species among late presenting AIDS patients in northwest Ethiopia","volume":"13","author":"Mulu","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0015","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0020","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0025","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1128\/JCM.02474-10","article-title":"Comparison of in vitro susceptibility characteristics of Candida species from cases of invasive candidiasis in solid organ and stem cell transplant recipients: Transplant-Associated Infections Surveillance Network (TRANSNET), 2001 to 2006","volume":"49","author":"Lockhart","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0030","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.2009.1754","article-title":"International study of the prevalence and outcomes of infection in intensive care units","volume":"302","author":"Vincent","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0035","doi-asserted-by":"crossref","first-page":"E343","DOI":"10.1111\/1469-0691.12212","article-title":"Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme","volume":"19","author":"Arendrup","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0040","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1590\/S0074-02762013000300005","article-title":"Historical trends in the epidemiology of candidaemia: analysis of an 11-year period in a tertiary care hospital in Brazil","volume":"108","author":"Wille","year":"2013","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0045","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1128\/JCM.00409-07","article-title":"Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing","volume":"45","author":"Pfaller","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0050","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1128\/AAC.00791-10","article-title":"Voriconazole-induced inhibition of the fungicidal activity of amphotericin B in Candida strains with reduced susceptibility to voriconazole: an effect not predicted by the MIC value alone","volume":"55","author":"Lignell","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0055","doi-asserted-by":"crossref","first-page":"528521","DOI":"10.1155\/2012\/528521","article-title":"Fungal biofilm resistance","volume":"2012","author":"Ramage","year":"2012","journal-title":"Int J Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0060","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1128\/AAC.47.5.1565-1570.2003","article-title":"Fungicidal synergism of fluconazole and cyclosporine in Candida albicans is not dependent on multidrug efflux transporters encoded by the CDR1, CDR2, CaMDR1, and FLU1 genes","volume":"47","author":"Marchetti","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0065","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1517\/14656566.2013.805204","article-title":"Invasive candidiasis: update on current pharmacotherapy options and future perspectives","volume":"14","author":"Tragiannidis","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0070","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijantimicag.2005.10.014","article-title":"In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida species","volume":"27","author":"Karlowsky","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0075","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1128\/AAC.01510-09","article-title":"Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis","volume":"55","author":"Chaturvedi","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0080","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.bbrc.2011.06.004","article-title":"Antifungal activity of lariciresinol derived from Sambucus williamsii and their membrane-active mechanisms in Candida albicans","volume":"410","author":"Hwang","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.micpath.2009.10.001","article-title":"Evolution of ergosterol biosynthesis inhibitors as fungicidal against Candida","volume":"48","author":"Ahmad","year":"2010","journal-title":"Microb Pathog"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0090","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejps.2012.09.016","article-title":"Reversal of efflux mediated antifungal resistance underlies synergistic activity of two monoterpenes with fluconazole","volume":"48","author":"Ahmad","year":"2013","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0095","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1248\/bpb.31.2234","article-title":"In vitro synergism of fluconazole and baicalein against clinical isolates of Candida albicans resistant to fluconazole","volume":"31","author":"Huang","year":"2008","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0100","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijantimicag.2009.04.011","article-title":"In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms","volume":"34","author":"Miceli","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0105","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/jac\/dkr512","article-title":"Antibiofilm activity of certain phytocompounds and their synergy with fluconazole against Candida albicans biofilms","volume":"67","author":"Khan","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0110","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1128\/AAC.48.1.41-47.2004","article-title":"Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans","volume":"48","author":"Alem","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0115","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1073\/pnas.0813394106","article-title":"Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease","volume":"106","author":"Cowen","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0120","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nrmicro1680","article-title":"Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections","volume":"5","author":"Steinbach","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0125","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1128\/AAC.06017-11","article-title":"Potent synergistic effect of doxycycline with fluconazole against Candida albicans is mediated by interference with iron homeostasis","volume":"56","author":"Fiori","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0130","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1128\/AAC.01728-09","article-title":"Mechanism of the synergistic effect of amiodarone and fluconazole in Candida albicans","volume":"54","author":"Gamarra","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0135","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1128\/AAC.01022-10","article-title":"The marine sponge-derived polyketide endoperoxide plakortide F acid mediates its antifungal activity by interfering with calcium homeostasis","volume":"55","author":"Xu","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0140","doi-asserted-by":"crossref","first-page":"292","DOI":"10.7883\/yoken.64.292","article-title":"Synergistic antifungal effect of lactoferrin with azole antifungals against Candida albicans and a proposal for a new treatment method for invasive candidiasis","volume":"64","author":"Kobayashi","year":"2011","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0145","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1097\/00003246-199908000-00072","article-title":"In vitro activity of rifampin\u2013minocyclin coating to Candida albicans","volume":"27","author":"Schierholz","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0150","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/jac\/28.1.71","article-title":"Isolation and identification of bacteria from subgingival plaque with low susceptibility to minocycline","volume":"28","author":"Wilson","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0155","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1590\/S1806-83242006000300004","article-title":"In vitro minocycline activity on superinfecting microorganisms isolated from chronic periodontitis patients","volume":"20","author":"de Oliveira","year":"2006","journal-title":"Braz Oral Res"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0160","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1567-1364.2010.00664.x","article-title":"The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents","volume":"10","author":"Shi","year":"2010","journal-title":"FEMS Yeast Res"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0165","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/1567-1364.12048","article-title":"Synergistic effect of doxycycline and fluconazole against Candida albicans biofilms and the impact of calcium channel blockers","volume":"13","author":"Gao","year":"2013","journal-title":"FEMS Yeast Res"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0170","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/jac\/46.3.397","article-title":"Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents","volume":"46","author":"Baillie","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0175","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.01397-07","article-title":"Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms","volume":"52","author":"Uppuluri","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0180","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1476-0711-11-27","article-title":"Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine","volume":"11","author":"Shinde","year":"2012","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0190","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.3346\/jkms.2010.25.12.1722","article-title":"In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms","volume":"25","author":"Ko","year":"2010","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0195","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/jac\/dkn473","article-title":"Comparative pharmacodynamic interaction analysis between ciprofloxacin, moxifloxacin and levofloxacin and antifungal agents against Candida albicans and Aspergillus fumigatus","volume":"63","author":"Stergiopoulou","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0200","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1128\/AAC.00735-07","article-title":"Isobolographic analysis of pharmacodynamic interactions between antifungal agents and ciprofloxacin against Candida albicans and Aspergillus fumigatus","volume":"52","author":"Stergiopoulou","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0205","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1128\/AAC.41.11.2518","article-title":"Effectiveness of quinolone antibiotics in modulating the effects of antifungal drugs","volume":"41","author":"Sugar","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0210","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1128\/AAC.39.7.1517","article-title":"In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination with amphotericin B and fluconazole against pathogenic fungi","volume":"39","author":"Nakajima","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0215","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s101560070014","article-title":"Synergistic effect of ofloxacin and fluconazole against azole-resistant Candida albicans","volume":"6","author":"Sasaki","year":"2000","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0220","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1469-0691.2005.01131.x","article-title":"Quinolones in 2005: an update","volume":"11","author":"Van Bambeke","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0225","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1128\/AAC.36.12.2778","article-title":"DNA topoisomerases from pathogenic fungi: targets for the discovery of antifungal drugs","volume":"36","author":"Shen","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0230","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1046\/j.1365-2958.2003.03495.x","article-title":"Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence","volume":"48","author":"Sanglard","year":"2003","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0235","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1128\/EC.00310-10","article-title":"Calcineurin controls drug tolerance, hyphal growth, and virulence in Candida dubliniensis","volume":"10","author":"Chen","year":"2011","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0240","doi-asserted-by":"crossref","first-page":"e44192","DOI":"10.1371\/journal.pone.0044192","article-title":"Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae","volume":"7","author":"Zhang","year":"2012","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0245","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1128\/EC.2.3.422-430.2003","article-title":"Calcineurin is essential for Candida albicans survival in serum and virulence","volume":"2","author":"Blankenship","year":"2003","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0250","doi-asserted-by":"crossref","first-page":"e48369","DOI":"10.1371\/journal.pone.0048369","article-title":"Calcium-activated-calcineurin reduces the in vitro and in vivo sensitivity of fluconazole to Candida albicans via Rta2p","volume":"7","author":"Jia","year":"2012","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0255","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s00018-008-8409-3","article-title":"RTA2 is involved in calcineurin-mediated azole resistance and sphingoid long-chain base release in Candida albicans","volume":"66","author":"Jia","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0260","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/AAC.41.1.156","article-title":"The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein","volume":"41","author":"Odom","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0265","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1128\/AAC.44.1.143-149.2000","article-title":"Immunosuppressive and nonimmunosuppressive cyclosporine analogs are toxic to the opportunistic fungal pathogen Cryptococcus neoformans via cyclophilin-dependent inhibition of calcineurin","volume":"44","author":"Cruz","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0270","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/emboj\/21.4.546","article-title":"Calcineurin is essential for survival during membrane stress in Candida albicans","volume":"21","author":"Cruz","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0275","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1128\/AAC.01070-07","article-title":"In vitro interactions between tacrolimus and azoles against Candida albicans determined by different methods","volume":"52","author":"Sun","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0280","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/AAC.44.9.2373-2381.2000","article-title":"Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans","volume":"44","author":"Marchetti","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0285","doi-asserted-by":"crossref","first-page":"e1002257","DOI":"10.1371\/journal.ppat.1002257","article-title":"Hsp90 governs dispersion and drug resistance of fungal biofilms","volume":"7","author":"Robbins","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0290","doi-asserted-by":"crossref","first-page":"e1001069","DOI":"10.1371\/journal.ppat.1001069","article-title":"PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90","volume":"6","author":"LaFayette","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0295","doi-asserted-by":"crossref","first-page":"e1000532","DOI":"10.1371\/journal.ppat.1000532","article-title":"Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin","volume":"5","author":"Singh","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0300","doi-asserted-by":"crossref","first-page":"e1000471","DOI":"10.1371\/journal.ppat.1000471","article-title":"Hsp90 orchestrates stress response signaling governing fungal drug resistance","volume":"5","author":"Cowen","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0305","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1159\/000351619","article-title":"Involvement of heat shock proteins in Candida albicans biofilm formation","volume":"23","author":"Becherelli","year":"2013","journal-title":"J Mol Microbiol Biotechnol"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0310","doi-asserted-by":"crossref","first-page":"e45109","DOI":"10.1371\/journal.pone.0045109","article-title":"Hsp90 is involved in apoptosis of Candida albicans by regulating the calcineurin\u2013caspase apoptotic pathway","volume":"7","author":"Dai","year":"2012","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0315","doi-asserted-by":"crossref","first-page":"e1003390","DOI":"10.1371\/journal.pgen.1003390","article-title":"Genetic and genomic architecture of the evolution of resistance to antifungal drug combinations","volume":"9","author":"Hill","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0320","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1567-1364.2009.00552.x","article-title":"Calcium homeostasis and signaling in yeast cells and cardiac myocytes","volume":"9","author":"Cui","year":"2009","journal-title":"FEMS Yeast Res"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0325","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1046\/j.1365-2958.2003.03291.x","article-title":"Amiodarone induces a caffeine-inhibited, MID1-dependent rise in free cytoplasmic calcium in Saccharomyces cerevisiae","volume":"47","author":"Courchesne","year":"2003","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0330","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/1471-2180-11-209","article-title":"The Aspergillus giganteus antifungal protein AFPNN5353 activates the cell wall integrity pathway and perturbs calcium homeostasis","volume":"11","author":"Binder","year":"2011","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0335","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/jac\/dkh385","article-title":"Release of calcium from intracellular stores and subsequent uptake by mitochondria are essential for the candidacidal activity of an N-terminal peptide of human lactoferrin","volume":"54","author":"Lupetti","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0340","doi-asserted-by":"crossref","first-page":"28831","DOI":"10.1074\/jbc.M303300200","article-title":"Antifungal activity of amiodarone is mediated by disruption of calcium homeostasis","volume":"278","author":"Gupta","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0345","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1074\/jbc.M806693200","article-title":"Membrane hyperpolarization drives cation influx and fungicidal activity of amiodarone","volume":"284","author":"Maresova","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0350","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1567-1364.2008.00354.x","article-title":"Fungicidal activity of amiodarone is tightly coupled to calcium influx","volume":"8","author":"Muend","year":"2008","journal-title":"FEMS Yeast Res"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0355","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1099\/jmm.0.47651-0","article-title":"Synergistic activity of azoles with amiodarone against clinically resistant Candida albicans tested by chequerboard and time\u2013kill methods","volume":"57","author":"Guo","year":"2008","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0360","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1124\/jpet.300.1.195","article-title":"Characterization of a novel, broad-based fungicidal activity for the antiarrhythmic drug amiodarone","volume":"300","author":"Courchesne","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0365","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1128\/AAC.01050-10","article-title":"Mechanism of antifungal activity of terpenoid phenols resembles calcium stress and inhibition of the TOR pathway","volume":"54","author":"Rao","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0370","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1128\/AAC.50.3.1096-1099.2006","article-title":"Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole","volume":"50","author":"Quan","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0375","doi-asserted-by":"crossref","first-page":"106583","DOI":"10.1155\/2012\/106583","article-title":"Potent antifungal activity of pure compounds from traditional Chinese medicine extracts against six oral Candida species and the synergy with fluconazole against azole-resistant Candida albicans","volume":"2012","author":"Yan","year":"2012","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0380","doi-asserted-by":"crossref","first-page":"e400","DOI":"10.1111\/j.1439-0507.2010.01935.x","article-title":"In vitro synergy of pseudolaric acid B and fluconazole against clinical isolates of Candida albicans","volume":"54","author":"Guo","year":"2011","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0385","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1099\/jmm.0.020693-0","article-title":"In vitro synergy of eugenol and methyleugenol with fluconazole against clinical Candida isolates","volume":"59","author":"Ahmad","year":"2010","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0390","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1399-302X.2004.00202.x","article-title":"Study of anticandidal activity of carvacrol and eugenol in vitro and in vivo","volume":"20","author":"Chami","year":"2005","journal-title":"Oral Microbiol Immunol"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0395","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.fitote.2007.02.022","article-title":"Eugenol and thymol, alone or in combination, induce morphological alterations in the envelope of Candida albicans","volume":"78","author":"Braga","year":"2007","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0400","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1248\/bpb.b12-00338","article-title":"Inhibitory effect of shikonin on Candida albicans growth","volume":"35","author":"Miao","year":"2012","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0405","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fmicb.2011.00047","article-title":"The antifungal plant defensin HsAFP1 from Heuchera sanguinea induces apoptosis in Candida albicans","volume":"2","author":"Aerts","year":"2011","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0410","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1099\/jmm.0.46172-0","article-title":"Prostaglandin production during growth of Candida albicans biofilms","volume":"54","author":"Alem","year":"2005","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0415","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00430-010-0169-7","article-title":"Effect of inhibitors of arachidonic acid metabolism on prostaglandin E2 production by Candida albicans and Candida dubliniensis biofilms","volume":"200","author":"Ells","year":"2010","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0420","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12223-011-0049-6","article-title":"Antifungal activity of some cyclooxygenase inhibitors on Candida albicans: PGE2-dependent mechanism","volume":"56","author":"de Quadros","year":"2011","journal-title":"Folia Microbiol (Praha)"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0425","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1439-0507.2004.01052.x","article-title":"Reassessment of the in vitro synergistic effect of fluconazole with the non-steroidal anti-inflammatory agent ibuprofen against Candida albicans","volume":"48","author":"Arai","year":"2005","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0430","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1567-1364.2009.00504.x","article-title":"Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes","volume":"9","author":"Ricardo","year":"2009","journal-title":"FEMS Yeast Res"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0435","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s10156-013-0639-0","article-title":"Combinatory effect of fluconazole and FDA-approved drugs against Candida albicans","volume":"19","author":"Kaneko","year":"2013","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0440","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1099\/jmm.0.2008\/001263-0","article-title":"Human recombinant lactoferrin acts synergistically with antimicrobials commonly used in neonatal practice against coagulase-negative staphylococci and Candida albicans causing neonatal sepsis","volume":"57","author":"Venkatesh","year":"2008","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0445","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fonc.2013.00017","article-title":"Immunotherapy of invasive fungal infection in hematopoietic stem cell transplant recipients","volume":"3","author":"Lehrnbecher","year":"2013","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijantimicag.2013.12.009_bib0450","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s12272-011-0307-9","article-title":"Combination immunotherapy of MAb B6.1 with fluconazole augments therapeutic effect to disseminated candidiasis","volume":"34","author":"Lee","year":"2011","journal-title":"Arch Pharm Res"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857914000028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857914000028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T19:58:09Z","timestamp":1688932689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857914000028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":90,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0924857914000028"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.12.009","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of fluconazole with non-antifungal agents: A promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}